Michael Kuske

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Candida Albicans

Dendritic Cells

Risk Assessment

Top Venues

International journal of molecular sciences

Reproduction (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Kuske, Maximilian Haist, Thomas Jung, Stephan Grabbe, Matthias Bros
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses? Cancers 14 (7) (2022)
Monika Bednarczyk, Carolina Medina-Montano, Frederic Julien Fittler, Henner Stege, Meike Roskamp, Michael Kuske, Christian Langer, Marco Vahldieck, Evelyn Montermann, Ingrid Tubbe, Nadine Röhrig, Andrzej Dzionek, Stephan Grabbe, Matthias Bros
Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells. International journal of molecular sciences 22 (6) (2021)
Carlo Schmitz, Seyedeh Zeynab Sadr, Hagen Körschgen, Michael Kuske, Jennifer Schoen, Walter Stöcker, Willi Jahnen-Dechent, Julia Floehr
The E-modulus of the oocyte is a non-destructive measure of zona pellucida hardening. Reproduction (Cambridge, England) 162 (4) (2021)
Thomas Jung, Maximilian Haist, Michael Kuske, Stephan Grabbe, Matthias Bros
Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond. International journal of molecular sciences 22 (18) (2021)